Evolent Health, Inc. EVH Proceeds From (Payments For) Issuance Of Long-Term Debt
Proceeds From (Payments For) Issuance Of Long-Term Debt at other companies
Other financials
Where this comes from
Reported directly by Evolent Health, Inc. in its filing.
Tagged under the XBRL concept evh:ProceedsFromPaymentsForIssuanceOfLongTermDebt.
The official record: Evolent Health, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Evolent Health, Inc.'s proceeds from (payments for) issuance of long-term debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Evolent Health, Inc.'s proceeds from (payments for) issuance of long-term debt?
- Evolent Health, Inc. (EVH) reported proceeds from (payments for) issuance of long-term debt of $0 in Q1 2026.
- How has Evolent Health, Inc.'s proceeds from (payments for) issuance of long-term debt changed year-over-year?
- Evolent Health, Inc.'s proceeds from (payments for) issuance of long-term debt increased by 100.0% year-over-year, from -$221M to $0.
- What does proceeds from (payments for) issuance of long-term debt mean?
- The net cash impact from the issuance of new long-term debt instruments or the repayment of existing debt obligations. This metric reflects the company's reliance on external debt financing to fund operations, acquisitions, or capital structure optimization. It is a primary indicator of the company's leverage strategy and access to credit markets.